Iovance Biotherapeutics

IOVA · NASDAQ

$14.86+$0.65 (+4.57%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $14.21

Latest news

NewsOct 6, 4:00 AM ET
Transcript: Iovance Biotherapeutics Q2 2026 Earnings Conference Call
Press releaseOct 1, 7:00 AM ETGlobe Newswire
Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
NewsSep 30, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
NewsSep 30, 10:28 AM ETHenry Khederian
Iovance Biotherapeutics Stock Pauses After Hitting New 52-Week High: What's Going On?
NewsSep 29, 9:39 PM ETShivdeep Dhaliwal
Fair Issac Corp., Iovance Biotherapeutics, Stablecoin Development Corp., Carnival Corp. and Micron: Why These 5 Stocks Are on Investors' Radars Today
NewsSep 29, 1:08 PM ETVandana Singh
Iovance Biotherapeutics’ Amtagvi Demand Drives 2026 Revenue Guidance Bump, Stock Soars
Press releaseSep 29, 12:12 PM ETGlobe Newswire
High-Stakes October has these Biotechs Entering Crucial Stretch
NewsSep 29, 12:01 PM ETAvi Kapoor
Crude Oil Down 1%; US Job Openings Fall In August
NewsSep 29, 10:26 AM ETAvi Kapoor
CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday
Press releaseSep 29, 7:00 AM ETGlobe Newswire
Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million
Press releaseSep 4, 8:00 AM ETGlobe Newswire
Iovance Biotherapeutics to Present at Upcoming Conferences
NewsAug 21, 10:07 AM ETHenry Khederian
Iovance Biotherapeutics Stock Is Trending Friday: What's Going On?
NewsAug 20, 1:14 PM ETVandana Singh
Why Iovance Biotherapeutics Stock Hit 52-Week High
NewsAug 6, 2:06 PM ETEvette Mitkov
Iovance (IOVA) Stock Soars After Better-Than-Expected Q2 Results
NewsAug 6, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
Press releaseAug 6, 12:31 PM ETGlobe Newswire
Why Investors Are Watching These Healthcare Movers
NewsAug 6, 8:06 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseAug 6, 7:01 AM ETGlobe Newswire
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
Press releaseJun 8, 9:01 AM ETGlobe Newswire
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
Press releaseJun 3, 4:05 PM ETGlobe Newswire
Iovance's Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
Press releaseJun 1, 8:30 AM ETGlobe Newswire
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
Press releaseJun 1, 7:30 AM ETGlobe Newswire
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
Press releaseMay 21, 8:05 AM ETGlobe Newswire
Iovance Biotherapeutics to Present at Upcoming Conference
Press releaseMay 7, 7:05 AM ETGlobe Newswire
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
NewsApr 10, 11:13 AM ET
Iovance Biotherapeutics Option Alert: Fri $4 Calls Sweep (3) Near The Bid: 2008 @ $0.401 Vs 3647 OI; Earnings 5/7 After Close [Est] Ref=$4.04
Press releaseMar 31, 8:49 PM ETPRNewswire
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
Press releaseMar 24, 10:00 AM ETPRNewswire
Advanced Cell-based Therapy Booming the Success for Healthcare Sector
NewsMar 12, 8:02 AM ETAvi Kapoor
Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
NewsMar 6, 1:06 PM ETVandana Singh
What's Going On With Iovance Biotherapeutics Stock On Friday?
Press releaseMar 5, 9:00 AM ETPRNewswire
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
NewsMar 3, 9:01 AM ET
A Glimpse Into The Expert Outlook On Iovance Biotherapeutics Through 4 Analysts
Press releaseFeb 26, 8:00 AM ETGlobe Newswire
Iovance Biotherapeutics to Present at Upcoming Conferences
NewsFeb 24, 2:14 PM ETVandana Singh
Iovance Biotherapeutics Explodes Over 20% — Early Trial Data Sparks Investor Frenzy
NewsFeb 24, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseFeb 24, 7:00 AM ETGlobe Newswire
Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
NewsFeb 23, 3:01 PM ET
Examining the Future: Iovance Biotherapeutics's Earnings Outlook
Press releaseNov 24, 8:30 AM ETGlobe Newswire
Biotech Valuations Rise as New Clinical Platforms Show Progress
NewsAug 19, 8:01 AM ETAvi Kapoor
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
NewsJul 23, 11:00 AM ETAvi Kapoor
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday
Press releaseJun 30, 9:00 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm
Press releaseJun 16, 9:00 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Transcript: Iovance Biotherapeutics Q2 2026 Earnings Conference Call

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

10 Health Care Stocks With Whale Alerts In Today’s Session

Iovance Biotherapeutics Stock Pauses After Hitting New 52-Week High: What's Going On?

Fair Issac Corp., Iovance Biotherapeutics, Stablecoin Development Corp., Carnival Corp. and Micron: Why These 5 Stocks Are on Investors' Radars Today

Iovance Biotherapeutics’ Amtagvi Demand Drives 2026 Revenue Guidance Bump, Stock Soars

High-Stakes October has these Biotechs Entering Crucial Stretch

Crude Oil Down 1%; US Job Openings Fall In August

CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday

Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million

Iovance Biotherapeutics to Present at Upcoming Conferences

Iovance Biotherapeutics Stock Is Trending Friday: What's Going On?

Why Iovance Biotherapeutics Stock Hit 52-Week High

Iovance (IOVA) Stock Soars After Better-Than-Expected Q2 Results

12 Health Care Stocks Moving In Thursday's Intraday Session

Why Investors Are Watching These Healthcare Movers

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet

Iovance's Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Iovance Biotherapeutics to Present at Upcoming Conference

Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates

Iovance Biotherapeutics Option Alert: Fri $4 Calls Sweep (3) Near The Bid: 2008 @ $0.401 Vs 3647 OI; Earnings 5/7 After Close [Est] Ref=$4.04

The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step

Advanced Cell-based Therapy Booming the Success for Healthcare Sector

Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

What's Going On With Iovance Biotherapeutics Stock On Friday?

Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types

A Glimpse Into The Expert Outlook On Iovance Biotherapeutics Through 4 Analysts

Iovance Biotherapeutics to Present at Upcoming Conferences

Iovance Biotherapeutics Explodes Over 20% — Early Trial Data Sparks Investor Frenzy

12 Health Care Stocks Moving In Tuesday's Intraday Session

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

Examining the Future: Iovance Biotherapeutics's Earnings Outlook

Biotech Valuations Rise as New Clinical Platforms Show Progress

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm